Table 1.
Phenotype | Polarization agents | Makers | Roles |
---|---|---|---|
M1 | LPS, IFN-γ, TNF-α, IL-1β, IL-17 | IL-1β, IL-6, IL-12, IL-23 | pro-inflammation |
TNF-α | pro-inflammation | ||
iNOS | oxidative damage | ||
MHC-II | antigen presentation | ||
CCL2, CCL5, CCL20 | chemokine | ||
CXCL10 | chemokine | ||
MMP2, MMP9 | matrix decomposition | ||
CD16, CD32 | phagocytosis, chemotaxis | ||
M2 | |||
M2a | IL-4, IL-13 | IL-4, IL-10 | anti-inflammation |
TGF-β | anti-inflammation | ||
CD36 | phagocytosis | ||
CD206 | phagocytosis | ||
CCL22 | chemokine | ||
Arg-1 | tissue regeneration | ||
Ym-1 | stabilizing extracellular matrix | ||
Fizz1 | tissue regeneration | ||
M2b | TLRs agonist, IL-1R ligands, Fc receptors | MCH-II | pro-inflammation |
CD86 | pro-inflammation | ||
IL-1RA | anti-inflammation | ||
IL-10 | anti-inflammation | ||
M2c | IL-10, TGF-β, glucocorticoid | CD163 | phagocytosis |
IGF-1 | tissue regeneration | ||
NGF | tissue regeneration | ||
BDNF | tissue regeneration | ||
NT3, NT4/5 | tissue regeneration | ||
Arg-1 | tissue regeneration | ||
YM-1 | stabilize extracellular matrix | ||
Fizz1 | tissue regeneration |
LPS, lipopolysaccharide; IFN-γ, interferon γ; TNF-α-II, tumor necrosis factor α; iNOS, inducible nitric oxide synthase; MHC-II, major histocompatibility complex II; MMP, matrix metalloproteinase; Arg-1, arginine 1; Ym-1, chitinase 3-like 3; IGF-1, insulin-like growth factor 1; NGF, nerve growth factor; BDNF, brain-derived neurotrophic factor; NT3, neurotrophin 3; NT4/5, neurotrophin 4/5; FIZZ1, resistin-like-α.